Royalty Pharma plcRPRXNASDAQ
LOADING
|||
EV to Sales: Discounted Valuation
Below historical average, slight contraction.
Left:
||||
Enterprise value to sales ratio
Latest
7.98
↓ 33% below average
Average (9y)
11.91
Historical baseline
Range
High:18.93
Low:7.74
CAGR
-9.2%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | 7.98 | +3.0% |
| 2023 | 7.74 | -23.7% |
| 2022 | 10.15 | +5.3% |
| 2021 | 9.65 | -15.5% |
| 2020 | 11.42 | -4.8% |
| 2019 | 11.99 | +5.7% |
| 2018 | 11.34 | -14.4% |
| 2017 | 13.26 | -20.3% |
| 2016 | 16.64 | -12.1% |
| 2015 | 18.93 | - |